Johnson & Johnson
JNJ · NYSE · Healthcare
SEC EDGARFilings checked 15 Sept 2026, 22:20 UTCFinancials checked 15 Sept 2026, 22:20 UTC
Annual reporting period: 2024-12-30 — 2025-12-28 · USD
Annual revenue$94.19BYear over year +6.0%
Annual net income$26.8BConsolidated net income
Annual operating income—Standard fact unavailable
Operating margin—Operating income / revenue
Revenue over time
ANNUALEach bar represents annual revenue for the fiscal year ending on the stated date. Compact amounts are rounded; exact values and filings are listed below.
Company & data
JOHNSON & JOHNSON
Pharmaceutical Preparations
Market: United States
Currency: USD
CIK: 200406
A recent filing date is not a new financial period. Annual figures may remain unchanged until the next annual report, even when new current reports are filed.
How this data is calculated →Annual financials & sources
CONSOLIDATED| FISCAL END | REVENUE | NET INCOME | OPERATING INCOME | SOURCE |
|---|---|---|---|---|
| 2025-12-28 | $94.19B94,193,000,000 USD | $26.8B26,804,000,000 USD | —— | Filing ↗ |
| 2024-12-29 | $88.82B88,821,000,000 USD | $14.07B14,066,000,000 USD | —— | Filing ↗ |
| 2023-12-31 | $85.16B85,159,000,000 USD | $35.15B35,153,000,000 USD | —— | Filing ↗ |
| 2023-01-01 | $79.99B79,990,000,000 USD | $17.94B17,941,000,000 USD | —— | Filing ↗ |
Amounts use currency-specific compact units. Exact amounts appear below each rounded value. An em dash means unavailable, not zero.